Bax and Bak are the critical complementary effectors of colorectal cancer cell apoptosis by chemopreventive resveratrol

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Anti-Cancer Drugs

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/01.CAD.0000203387.29916.8EPMID 16550006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf.

  2005cited by this paper
• Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells

  2004cited by this paper
• Sensitization for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by the Chemopreventive Agent Resveratrol

  2004cited by this paper
• Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells

  2004cited by this paper
• Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex

  2004cited by this paper
• The Pathophysiology of Mitochondrial Cell Death

  2004cited by this paper
• Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy

  2003cited by this paper
• Resveratrol: from grapevines to mammalian biology

  2003cited by this paper
• Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.

  2002cited by this paper
• Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells

  2002cited by this paper
• The basis for the chemopreventive action of resveratrol.

  2002cited by this paper
• Resveratrol, a tumor‐suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl‐2

  2001cited by this paper
• Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts

  2001cited by this paper
• Resveratrol Inhibits Intestinal Tumorigenesis and Modulates Host-Defense-Related Gene Expression in an Animal Model of Human Familial Adenomatous Polyposis

  2001cited by this paper
• Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach.

  2001cited by this paper
• Biological Effects of Resveratrol

  2001cited by this paper
• Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse

  2001cited by this paper
• Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

  2001cited by this paper
• The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.

  2000cited by this paper
• Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.

  2000cited by this paper
• Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation1

  2000cited by this paper
• Biological effects of resveratrol.

  2000cited by this paper
• Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging

  2000cited by this paper
• tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c.

  2000cited by this paper
• Role of BAX in the apoptotic response to anticancer agents.

  2000cited by this paper
• Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase.

  2000cited by this paper
• Death Signal-induced Localization of p53 Protein to Mitochondria

  2000cited by this paper
• Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

  1999cited by this paper
• Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2.

  1999cited by this paper
• Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway.

  1999cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells.

  1998cited by this paper

• Resveratrol and p53: How are they involved in CRC plasticity and apoptosis?

  2024cites this paper
• Applications of resveratrol in the treatment of gastrointestinal cancer.

  2022cites this paper
• A nitric oxide-releasing prodrug promotes apoptosis in human renal carcinoma cells: Involvement of reactive oxygen species

  2021cites this paper
• Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs

  2021cites this paper
• JS-K promotes apoptosis by inducing ROS production in human prostate cancer cells

  2016cites this paper
• RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia

  2015influential citation
• Resveratrol: from basic studies to bedside.

  2014cites this paper
• Basic and Translational Research on Dietary Phytochemicals and Cancer Prevention

  2013cites this paper
• Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy

  2013cites this paper
• Importance of lipid microdomains, rafts, in absorption, delivery, and biological effects of resveratrol

  2013cites this paper
• Resveratrol and cancer treatment: is hormesis a yet unsolved matter?

  2013cites this paper
• Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents.

  2012cites this paper
• Induction of Apoptosis by Polyphenolic Compounds in Cancer Cells

  2012cites this paper
• Activation of a non-genomic Pim-1/Bad-Pser75 module is required for an efficient pro-survival effect of Bcl-xL induced by androgen in LNCaP cells.

  2011cites this paper
• Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe.

  2011cites this paper
• Angiogenesis as a potential target of pharmaconutrients in cancer therapy

  2010cites this paper
• Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state.

  2009cites this paper
• Bortezomib-induced Apoptosis in the Treatment of Non-small Cell Lung Cancer

  2009cites this paper
• The effects of resveratrol and tannic acid on apoptosis in colon adenocarcinoma cell line.

  2009cites this paper
• Is there a role for wine in cancer and the degenerative diseases of aging

  2009influential citation
• Resveratrol as an Inhibitor of Carcinogenesis

  2008cites this paper
• Stimulatory Heterotrimeric GTP-binding Protein Inhibits Hydrogen Peroxide-induced Apoptosis by Repressing BAK Induction in SH-SY5Y Human Neuroblastoma Cells*

  2008cites this paper
• Anti-Cancer Drugs 2008 Author Index to Volume 19.

  2008cites this paper